Detalles de la búsqueda
1.
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.
Circulation
; 133(18): 1772-82, 2016 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994121
2.
Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Clin Chem
; 63(2): 573-584, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27932413
3.
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention.
Eur Heart J
; 37(16): 1296-303, 2016 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26586786
4.
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement.
Circulation
; 131(1): 62-73, 2015 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25400062
5.
Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.
Am Heart J
; 173: 57-66, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26920597
6.
Comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the Assessing Angiography (A2) project.
Circulation
; 127(17): 1793-800, 2013 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-23470859
7.
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
JAMA
; 312(10): 1006-15, 2014 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25173516
8.
Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
Am Heart J
; 165(4): 509-514.e7, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23537966
9.
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
Am Heart J
; 166(5): 913-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24176448
10.
International variation in and factors associated with hospital readmission after myocardial infarction.
JAMA
; 307(1): 66-74, 2012 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22215167
11.
Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement".
Circulation
; 132(13): e166-7, 2015 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26416639
12.
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.
Circulation
; 122(21): 2131-41, 2010 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-21060072
13.
Appropriateness of percutaneous coronary intervention.
JAMA
; 306(1): 53-61, 2011 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-21730241
14.
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.
Eur Heart J
; 30(16): 2019-28, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19502623
15.
Response to letters regarding article, "comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the assessing angiography (A2) project".
Circulation
; 128(24): e463-4, 2013 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-24344070
16.
Interleukin-18 in patients with acute coronary syndromes.
Clin Cardiol
; 42(12): 1202-1209, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31596518
17.
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation
; 115(19): 2549-69, 2007 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17502590
18.
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation
; 115(19): 2570-89, 2007 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17502591
19.
Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.
Am Heart J
; 156(6): 1035-44, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19032997
20.
Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy.
Neurology
; 90(14): e1212-e1221, 2018 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29500292